![(6R-trans)-7-amino-3-[([5-(carboxymethyl)-4-methyl-2-thiazolyl]thio)methyl]-8-oxo-5-thia-1-azabicy…](https://static.cymitquimica.com/cas-image/313460-6r-trans-7-amino-3-5-carboxymethyl-4-methyl-2-thiazolyl-thio-methyl-8-oxo-5-thia-1-azabicyclo-4-2-0-oct-2-en-2-carboxylic-acid.png)
CAS: 111298-82-9 - (6R-trans)-7-amino-3-[([5-(carboxymethyl)-4-methyl-2-thiazolyl]thio)methyl]-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-2-carboxylic acid
Formula:C14H15N3O5S3
InChI:InChI=1S/C14H15N3O5S3/c1-5-7(2-8(18)19)25-14(16-5)24-4-6-3-23-12-9(15)11(20)17(12)10(6)13(21)22/h9,12H,2-4,15H2,1H3,(H,18,19)(H,21,22)/t9-,12-/m1/s1
InChI key:InChIKey=ZVSNBXDHZADFDJ-BXKDBHETSA-N
SMILES:O=C(O)C1=C(CSC2=NC(=C(S2)CC(=O)O)C)CSC3N1C(=O)C3N
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Cefodizime Impurity 4 HCl REF: 4Z-C-313009CAS: 111298-82-9 | - - - | To inquire | Tue 10 Dec 24 |
 | TACS REF: TR-T004200CAS: 111298-82-9 | - - - | 216.00 €~1,603.00 € | Tue 17 Dec 24 |
 | TACS REF: 3D-LEA29882CAS: 111298-82-9 | Min. 95% | To inquire | Tue 21 Jan 25 |
Cefodizime Impurity 4 HCl
CAS:111298-82-9
Formula:
C14H15N3O5S3·HCl
Color and Shape:
Off-White Solid
Molecular weight:
401.48 36.46
Ref: 4Z-C-313009
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
TACS
Controlled ProductCAS:111298-82-9
Applications TACS can be used as reactant/reagent for synthesis, antibacterial activity, pharmacokinetics, and acute toxicity …
Formula:
C14H15N3O5S3
Color and Shape:
Neat
Molecular weight:
401.48
Ref: TR-T004200
| 10mg | 216.00 € | ||
| 50mg | 907.00 € | ||
| 100mg | 1,603.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
TACS
CAS:111298-82-9
TACS is a medicinal product that has been developed to target cancer cells and induce …
Formula:
C14H15N3O5S3
Purity:
Min. 95%
Molecular weight:
401.5 g/mol
Ref: 3D-LEA29882
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
